Protara Therapeutics, Inc.TARANASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank85
5Y CAGR-1.6%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-1.6%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$181000.00-
2024$0.00-100.0%
2023$341000.00-
2022$0.00-
2021$0.00-100.0%
2020$196000.00+1125.0%
2019$16000.00-86.1%
2018$115000.00-22.3%
2017$148000.00+20.3%
2016$123000.00-